_version_ 1785091084965117952
author Delfau-Larue, Marie-Helene
Gomes, Lucie
Cartron, Guillaume
Morschhauser, Franck
Gros, Francois-Xavier
Gastinne, Thomas
Oberic, Lucie
Bachy, Emmanuel
Feugier, Pierre
Duléry, Rémy
Menard, Cedric
Pangault, Celine
Claudel, Alexis
Quelen, Cathy
Portugues, Cedric
Viailly, Pierre-Julien
Lemonnier, Francois
Itti, Emmanuel
Bailly, Clément
Laurent, Camille
Houot, Roch
author_facet Delfau-Larue, Marie-Helene
Gomes, Lucie
Cartron, Guillaume
Morschhauser, Franck
Gros, Francois-Xavier
Gastinne, Thomas
Oberic, Lucie
Bachy, Emmanuel
Feugier, Pierre
Duléry, Rémy
Menard, Cedric
Pangault, Celine
Claudel, Alexis
Quelen, Cathy
Portugues, Cedric
Viailly, Pierre-Julien
Lemonnier, Francois
Itti, Emmanuel
Bailly, Clément
Laurent, Camille
Houot, Roch
author_sort Delfau-Larue, Marie-Helene
collection PubMed
description
format Online
Article
Text
id pubmed-10430960
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104309602023-08-17 P1123: EARLY CTDNA CLEARANCE AFTER CAR T-CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B-CELL LYMPHOMA: RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY Delfau-Larue, Marie-Helene Gomes, Lucie Cartron, Guillaume Morschhauser, Franck Gros, Francois-Xavier Gastinne, Thomas Oberic, Lucie Bachy, Emmanuel Feugier, Pierre Duléry, Rémy Menard, Cedric Pangault, Celine Claudel, Alexis Quelen, Cathy Portugues, Cedric Viailly, Pierre-Julien Lemonnier, Francois Itti, Emmanuel Bailly, Clément Laurent, Camille Houot, Roch Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430960/ http://dx.doi.org/10.1097/01.HS9.0000971388.52627.95 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Delfau-Larue, Marie-Helene
Gomes, Lucie
Cartron, Guillaume
Morschhauser, Franck
Gros, Francois-Xavier
Gastinne, Thomas
Oberic, Lucie
Bachy, Emmanuel
Feugier, Pierre
Duléry, Rémy
Menard, Cedric
Pangault, Celine
Claudel, Alexis
Quelen, Cathy
Portugues, Cedric
Viailly, Pierre-Julien
Lemonnier, Francois
Itti, Emmanuel
Bailly, Clément
Laurent, Camille
Houot, Roch
P1123: EARLY CTDNA CLEARANCE AFTER CAR T-CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B-CELL LYMPHOMA: RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY
title P1123: EARLY CTDNA CLEARANCE AFTER CAR T-CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B-CELL LYMPHOMA: RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY
title_full P1123: EARLY CTDNA CLEARANCE AFTER CAR T-CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B-CELL LYMPHOMA: RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY
title_fullStr P1123: EARLY CTDNA CLEARANCE AFTER CAR T-CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B-CELL LYMPHOMA: RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY
title_full_unstemmed P1123: EARLY CTDNA CLEARANCE AFTER CAR T-CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B-CELL LYMPHOMA: RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY
title_short P1123: EARLY CTDNA CLEARANCE AFTER CAR T-CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B-CELL LYMPHOMA: RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY
title_sort p1123: early ctdna clearance after car t-cell infusion predicts outcome in patients with large b-cell lymphoma: results from alycante, a phase 2 lysa study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430960/
http://dx.doi.org/10.1097/01.HS9.0000971388.52627.95
work_keys_str_mv AT delfaularuemariehelene p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT gomeslucie p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT cartronguillaume p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT morschhauserfranck p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT grosfrancoisxavier p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT gastinnethomas p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT obericlucie p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT bachyemmanuel p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT feugierpierre p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT duleryremy p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT menardcedric p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT pangaultceline p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT claudelalexis p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT quelencathy p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT portuguescedric p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT viaillypierrejulien p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT lemonnierfrancois p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT ittiemmanuel p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT baillyclement p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT laurentcamille p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy
AT houotroch p1123earlyctdnaclearanceaftercartcellinfusionpredictsoutcomeinpatientswithlargebcelllymphomaresultsfromalycanteaphase2lysastudy